Oxford BioMedica Share Price (OXB)

8.15 +0.15 (+1.88%) delayed: 11:13PM BST
Bid price 8.00 Open price 7.75
Ask price 8.15 Prev close 8.15
High price 8.16 Spread 1.84%
Low price 7.68 Volume 1,641,372

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 8.15 Net Gearing (%) -10.14
Market Capitalisation (£m) 205.49 Gross Gearing (%) 31.85
Shares in issue (m) 2,568.59 Debt Ratio 6.25
P/E Ratio -18.61 Debt-to-Equity Ratio 0.14
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.47
Dividend Yield (%) 0.00 Price to book value 8.92
Dividend cover (x) 0.00 ROCE -0.54
Earning per share (p) -0.43 EPS Growth (%) 45.57
52 week high / low 13.25 / 3.38 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
01/07/2015 BUY Martin Diggle NED 284,439
30/06/2015 BUY Martin Diggle NED 775,000
19/06/2015 BUY Martin Diggle NED 225,000
17/06/2015 BUY Andrew Heath NED 100,000
16/06/2015 BUY Tim Watts FD 116,931

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

09:56 27/08/2015

Higher half year net losses at Oxford Biomedica

Oxford BioMedica (LSE: OXB), ("OXB" or "the Group") a leading gene and cell therapy group, has announced that for the six months ended 30 June 2015 revenue was £4.4m (H1 2014: £4.7 million) due in large part to the Novartis contract. The net loss was £6.1m (H1 2014: £4.8m). Research and...

07:00 27/08/2015

Interim Results

/* */ RNS Number : 2197X Oxford Biomedica PLC 27 August 2015    OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015   Oxford, UK - 27 August 2015: Oxford BioMedica plc (LSE: OXB), ("OXB" or "the Group") a leading gene and cell...

17:16 06/08/2015

Holding(s) in Company

/* */ RNS Number : 3766V Oxford Biomedica PLC 06 August 2015   TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are...

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

4 months ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one....

more than 1 year ago


Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago


Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions